Skip to main content
  1. Home
  2. Emerging Tech
  3. News

New startup promises ‘world’s first’ CRISPR-powered disease detection

Dyllan Furness
By
The Mammoth CRISPR Platform

Over the past few years, the gene-editing tool CRISPR has breathed new life into the field of genetics. Suddenly, genetic engineering was deemed both simple and efficient. CRISPR has been used to make specific tweaks to the genomes of myriad plants and animals, editing things like horns out of cattle and disease-resistance into crops.

Now, a startup called Mammoth Biosciences promises to offer unprecedented disease diagnostics, using CRISPR to detect biomarkers associated with practically any disease. Co-founded by Jennifer Doudna, one of the two researchers who first put the revolutionary tool on the map, Mammoth has branded itself as the world’s first CRISPR-powered diagnostic platform, offering high-tech disease detection via at-home tests.

Recommended Videos

The system will perform detection of any organism that contains DNA and RNA, according to the company, meaning every infectious disease (like STDs, influenza, and malaria) and even cancers can be targets.

Related

“Similar to a search engine, our scientists enter a code into the guide RNA to find the matching nucleic acid (DNA or RNA) strand in the disease,” Mammoth CEO Trevor Martin told Digital Trends. “Once the code is found, instead of only snipping the strand of matched RNA or DNA like one would for editing, it also has a collateral effect on reporter molecules that release a color to visually show the presence of the disease.

“For an at-home test, our vision is to have these molecules present on a disposable, credit card-sized paper test strip, which will be able to detect multiple tests on one strip,” he added. “It’s as easy as taking an at-home pregnancy test. You simply add a liquid sample to the strip and use the Mammoth app to read out the result. You’ll receive the result in under an hour.”

If we’ve learned anything about diagnostics startups who make big promises, it’s to filter their claims through a healthy dose of skepticism. That said, if Mammoth’s ambitions hold true, it would mean huge changes in efficiency and productivity for fields like healthcare and agriculture.

Martin wouldn’t share specifics on how much these at-home tests would cost but he insisted that the system would be, “affordable and as simple as taking an at-home pregnancy test.”

He added, “Our vision is to democratize access and knowledge to your own health and make it more accessible, so affordability is a priority.”

Editors' Recommendations

Topics
Dyllan Furness
Dyllan Furness
Contributor
Dyllan Furness is a freelance writer from Florida. He covers strange science and emerging tech for Digital Trends, focusing…
New CRISPR technique could accelerate a cure for Huntington’s disease and ALS
The ODIN DIY CRISPR kit

Just a few weeks ago, we marveled at the first instance of human embryo editing with CRISPR in the United States. Now, the gene editing technique has been used for yet another impressive purpose. Scientists at the University of California San Diego believe that a modified version of the CRISPR/Cas9 tool could be used to track RNA in live cells using a method known as RNA-targeting Cas9. But more importantly, this methodology could allow doctors to fix molecular mistakes that result in diseases like myotonic dystrophy types 1 and 2, which are the most common form of hereditary ALS and Huntington's disease.

These types of diseases occur when errors in RNA sequences prevent the production of key proteins. However, with RNA-targeting Cas9, researchers were able to get rid of the RNA errors, particularly those linked to ALS and Huntington's. In fact, so effective was this new methodology that scientists were able to remove more than 95 percent of the problematic RNA.

Read more
New gene-edited pigs may now be resistant to billion-dollar disease
gene edit pigs crispr ucdavispig wr

Scientists think they have edited made pigs resistant to a billion-dollar virus by editing susceptibility out of the genome.

Using a revolutionary new tool called CRISPR/Cas9, the team of researchers from the University of Edinburgh’s Roslin Institute in Scotland, and animal biotech company Genus have create piglets that lack a portion of the gene that makes them susceptible to Porcine Reproductive and Respiratory Syndrome (PRRS). They published a paper detailing their work last week in the journal PLOS Pathogens.

Read more
Chinese scientists have created the world’s first genetically engineered human embryo
human embryo

According to a recently-published study in Protein & Cell, a group of scientists at Sun Yat-sen University in Guangzhou, China have created the first genetically modified human embryos. Rumors have been circulating for some time that this had already been done, but prior to now, there was no official scientific documentation to back it up. Today, it's official.

To accomplish this feat, the researchers used a technique called CRISPR, which (in very simple terms) seeks out genes that cause genetically-inherited diseases. The procedure involves injecting embryos with the enzyme complex CRISPR/Cas9, which binds to and splices DNA at specific locations. This complex can be programmed to target problematic genes and replace them with different molecules, which effectively neutralizes them before a person is born. The technique has been demonstrated in animal embryos and in adult human cells, but this is the first published study that deals with human embryos.

Read more